{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T12:22:10Z","timestamp":1772886130003,"version":"3.50.1"},"reference-count":48,"publisher":"Akademiai Kiado Zrt.","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Physiologica Hungarica"],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1556\/aphysiol.98.2011.3.2","type":"journal-article","created":{"date-parts":[[2011,9,7]],"date-time":"2011-09-07T01:44:15Z","timestamp":1315359855000},"page":"252-261","source":"Crossref","is-referenced-by-count":4,"title":["Non-ST elevation myocardial infarction: A new pathophysiological concept could solve the contradiction between accepted cause and clinical observations"],"prefix":"10.1556","volume":"98","author":[{"given":"Mih\u00e1ly","family":"Medvegy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Simonyi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Medvegy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zs.","family":"P\u00e9csv\u00e1rady","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"425","reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2007.02.013","article-title":"ACC\/AHA 2007 Guidelines for the management of patients with unstable angina\/non-ST-elevation myocardial infarction","volume":"50","author":"Anderson J.L.","year":"2007","journal-title":"J. Am. Coll. Cardiol."},{"key":"2","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/0022-0736(88)90109-4","article-title":"Correlation of electrocardiologic and pathologic findings in 100 cases of Q wave and non-Q wave myocardial infarction","volume":"21","author":"Antaloczy Z.","year":"1988","journal-title":"J. Electrocardiol."},{"key":"3","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1185\/030079902125000787","article-title":"Treatment with atorvastatin to the National Cholesterol Educational Program goal versus \u2018usual\u2019 care in secondary coronary heart disease prevention. The GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study","volume":"18","author":"Athyros V.G.","year":"2002","journal-title":"Curr. Med. Res. Opin."},{"key":"4","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1093\/eurheartj\/ehm161","article-title":"Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes","volume":"28","author":"Bassand J.P.","year":"2007","journal-title":"Eur. Heart. J."},{"key":"5","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0021-9150(01)00532-9","article-title":"Atorvastatin improves blood rheology in patients with familial hypercholesterolemia (FH) on long-term LDL apheresis treatment","volume":"159","author":"Banyai S.","year":"2001","journal-title":"Atherosclerosis"},{"key":"6","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1016\/S0735-1097(02)02336-7","article-title":"ACC\/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction","volume":"40","author":"Braunwald E.","year":"2002","journal-title":"J. Am. Coll. Cardiol."},{"key":"7","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1056\/NEJM198811173192002","article-title":"Angina due to microvascular disease in hypertensive patients without left ventricular hypertrophy","volume":"319","author":"Brush J.E.","year":"1988","journal-title":"N. Eng. J. Med."},{"key":"8","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1161\/01.CIR.0000029926.71825.E2","article-title":"Benefit of clopidogrel in patients with acute coronary syndromes without ST-segment elevation in various risk groups","volume":"10","author":"Budaj A.","year":"2002","journal-title":"Circulation"},{"key":"9","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1056\/NEJMra061889","article-title":"Medical progress: coronary microvascular dysfunction","volume":"356","author":"Camici P.G.","year":"2007","journal-title":"N. Eng. J. Med."},{"key":"10","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1016\/0002-9149(88)91180-0","article-title":"\u201cMicrovascular angina\u201d as a cause of chest pain with angiographically normal coronary arteries","volume":"61","author":"Cannon R.O.","year":"1988","journal-title":"Am. J. Cardiol."},{"key":"11","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1136\/hrt.2003.020594","article-title":"Angina pectoris and normal coronary arteries: cardiac syndrome X","volume":"90","author":"Crea F.","year":"2004","journal-title":"Heart"},{"key":"12","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1001\/jama.292.11.1307","article-title":"A to Z Investigators. Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial","volume":"292","author":"Lemos J.A.","year":"2004","journal-title":"JAMA"},{"key":"13","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/S0735-1097(02)02050-8","article-title":"CAPE II Trial Investigators. Medical treatment of myocardial ischemia in coronary artery disease: effect of drug regime and irregular dosing in the CAPE II trial","volume":"40","author":"Deanfield J.E.","year":"2002","journal-title":"J. Am. Coll. Cardiol."},{"key":"14","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.biopha.2009.06.004","article-title":"Inflammatory markers and cardiac function in acute coronary syndrome: difference in ST-segment elevation myocardial infarction (STEMI) and in non-STEMI models","volume":"63","author":"Stefano R.","year":"2009","journal-title":"Biomed. Pharmacother."},{"key":"15","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/S0002-9149(99)00745-6","article-title":"Effect of atorvastatin on hemorheologic-hemostatic parameters and serum fibrinogen levels in hyperlipidemic patients","volume":"85","author":"Dujovne C.A.","year":"2000","journal-title":"Am. J. Cardiol."},{"key":"16","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1001\/jama.257.17.2318","article-title":"Leukocytes and the risk of ischemic heart diseases","volume":"257","author":"Ernst E.","year":"1987","journal-title":"JAMA"},{"key":"17","doi-asserted-by":"crossref","unstructured":"Fox K, Ford I, Steg PG, Tendera M, Ferrari: On behalf of the BEAUTIFUL. Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomized, double-blind, placebo-controlled trial. Lancet DOI:10.1016\/S0140-6736(08)61170-8 (2008)","DOI":"10.1016\/S0140-6736(08)61170-8"},{"key":"18","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/S0140-6736(03)14286-9","article-title":"EURopean trial on reduction of cardiac events with Perindopril in stable coronary Artery disease Investigators. Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study)","volume":"362","author":"Fox K.M.","year":"2003","journal-title":"Lancet"},{"key":"19","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/S0735-1097(99)00599-9","article-title":"Restenosis and clinical outcome in patients treated with amlodipine after angioplasty: results from the Coronary AngioPlasty Amlodipine REStenosis Study (CAPARES)","volume":"35","author":"Jorgensen B.","year":"2000","journal-title":"J. Am. Coll. Cardiol."},{"key":"20","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1185\/03007997909109520","article-title":"The use of pentoxiphyllin in the treatment of ischemic heart disease","volume":"6","author":"Kobaladze S.G.","year":"1979","journal-title":"Current Medical Research and Opinion"},{"key":"21","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1056\/NEJMoa050461","article-title":"Treating to New Targets (TNT) Investigators. Intensive lipid lowering with atorvastatin in patients with stable coronary disease","volume":"352","author":"LaRosa J.C.","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"22","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.1161\/hc4801.100358","article-title":"Attenuation of rebound ischemia after discontinuation of heparin therapy by glycoprotein IIb\/IIIa inhibition with eptifibatide in patients with acute coronary syndromes: observations from the Platelet IIb\/IIIa in Unstable angina: Receptor Suppression Using Integrilin Therapy (PURSUIT) trial","volume":"104","author":"Lauer M.A.","year":"2001","journal-title":"Circulation"},{"key":"23","doi-asserted-by":"crossref","unstructured":"Lerman A, Holmes DR, Herrmann J, Gersch BJ: Microcirculatory dysfunction in ST-elevation myocardial infarction: cause, consequence, or both? Eur. Heart. J. Advance doi:10.1093\/eurheartj\/ehl501 Access published online on March 8, (2007)","DOI":"10.1093\/eurheartj\/ehl501"},{"key":"24","first-page":"533","article-title":"Blood rheology, cardiovascular risk factors, and cardiovascular disease: The West of Scotland Coronary Prevention Study","volume":"84","author":"Lowe G.","year":"2000","journal-title":"Thromb. Haemost."},{"key":"25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1161\/01.CIR.82.1.1","article-title":"Understanding the coronary circulation through studies at microvascular level","volume":"82","author":"Marcus M.L.","year":"1990","journal-title":"Circulation"},{"key":"26","volume-title":"The paradox of angina persisting after coronary revascularization","author":"Marzilli M.","year":"2006"},{"key":"27","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0735-1097(99)00554-9","article-title":"Coronary microcirculatory vasoconstriction during ischemia in patients with unstable angina","volume":"35","author":"Marzilli M.","year":"2000","journal-title":"J. Am. Coll. Cardiol."},{"key":"28","first-page":"1109","article-title":"Simple, quantitative body surface potential map parameters in the diagnosis of remote Q-wave and non-Q-wave myocardial infarction","volume":"20","author":"Medvegy M.","year":"2004","journal-title":"Can. J. Cardiol"},{"key":"29","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0828-282X(08)70549-X","article-title":"Diagnosis and discrimination of remote antero- and inferoseptal non-Q wave myocardial infarctions with body surface potential mapping","volume":"24","author":"Medvegy M.","year":"2008","journal-title":"Can. J. Cardiol"},{"key":"30","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1161\/01.CIR.101.10.1115","article-title":"A new body surface isopotential map evaluation method to detect minor potential losses in non-Q wave myocardial infarction","volume":"101","author":"Medvegy M.","year":"2000","journal-title":"Circulation"},{"key":"31","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1093\/eurheartj\/ehm031","article-title":"STEMI and NSTEMI: are they so different? 1-year outcomes in acute myocardial infarction as defined by the ESC\/ACC definition (the Opera registry)","volume":"28","author":"Montalescot G.","year":"2007","journal-title":"Eur. Heart J."},{"key":"32","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1001\/jama.292.18.2217","article-title":"Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trial","volume":"292","author":"Nissen S.E.","year":"2004","journal-title":"JAMA"},{"key":"33","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s102380300014","article-title":"T cell activation and enhanced apoptosis in non-ST elevation myocardial infarction","volume":"3","author":"Pasqui A.L.","year":"2003","journal-title":"Clinical and Experimental Medicine"},{"key":"34","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1056\/NEJM199912093412402","article-title":"The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group","volume":"341","author":"Poldermans D.","year":"1999","journal-title":"New Engl. J. Med."},{"key":"35","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1016\/j.ehj.2003.08.005","article-title":"Statin therapy: new therapy for cardiac microvascular dysfunction","volume":"24","author":"Rosenson R.S.","year":"2003","journal-title":"Eur. Heart J."},{"key":"36","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1093\/eurheartj\/ehm368","article-title":"STEMI and NSTEMI are two distinct pathophysiological entities","volume":"28","author":"Rott D.","year":"2007","journal-title":"Eur. Heart J."},{"key":"37","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0033-0620(75)90001-8","article-title":"Regulation of coronary blood flow","volume":"18","author":"Rubio R.","year":"1975","journal-title":"Prog. Cardiovasc. Dis."},{"key":"38","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1161\/01.CIR.103.19.2352","article-title":"Paradoxical increase in microvascular resistance during tachycardia downstream from a severe stenosis in patients with coronary artery disease: reversal by angioplasty","volume":"103","author":"Sambuceti G.","year":"2001","journal-title":"Circulation"},{"key":"39","doi-asserted-by":"crossref","first-page":"H2298","DOI":"10.1152\/ajpheart.00870.2004","article-title":"Coronary microcirculatory vasoconstriction is heterogeneously distributed in acutely ischemic myocardium","volume":"288","author":"Sambuceti G.","year":"2005","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"40","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jacc.2004.04.036","article-title":"The decrease of plaque volume during percutaneous coronary intervention has a negative impact coronary flow in acute myocardial infarction: a major role of percutaneous coronary intervention-induced embolization","volume":"44","author":"Sato H.","year":"2004","journal-title":"J. Am. Coll. Cardiol."},{"key":"41","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1001\/jama.285.13.1711","article-title":"Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study Investigators. Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial","volume":"285","author":"Schwartz G.G.","year":"2001","journal-title":"JAMA"},{"key":"42","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/S0140-6736(02)11600-X","article-title":"PROspective Study of Pravastatin in the Elderly at Risk. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial","volume":"360","author":"Shepherd J.","year":"2002","journal-title":"Lancet"},{"key":"43","doi-asserted-by":"crossref","unstructured":"Steen H, Giannitsis E, Futterer S, Merten C, Juenger C, Katus HA: Cardiac troponin T at 96 hours after acute myocardial infarction correlates with infarct size and cardiac function. J. Am. Coll. Cardiol. doi:10.1016\/j.jacc.2006.06.002 published online Nov 8 (2006)","DOI":"10.1016\/j.jacc.2006.06.002"},{"key":"44","first-page":"430","article-title":"Register of Information and Knowledge About Swedish Heart Intensive Care Admissions","volume":"285","author":"Stenestrand U.","year":"2001","journal-title":"JAMA"},{"key":"45","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1093\/oxfordjournals.eurheartj.a014797","article-title":"Fibrinogen, viscosity and the 10-year incidence of ischemic heart disease","volume":"17","author":"Sweetnam P.M.","year":"1996","journal-title":"Eur. Heart J."},{"key":"46","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.jelectrocard.2010.02.002","article-title":"Diagnostic value of body surface potential mapping in assessment of the coronary artery lesion after angina pectoris and without repolarization changes on the ECG","volume":"49","author":"Sz\u0171cs E.","year":"2010","journal-title":"J. Electrocardiol."},{"key":"47","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1161\/01.CIR.89.4.1545","article-title":"Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q wave myocardial infarction: results of the TIMI IIIB trial. Thrombolysis In Myocardial Ischaemia","volume":"89","year":"1994","journal-title":"Circulation"},{"key":"48","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJM200001203420301","article-title":"Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators","volume":"342","author":"Yusuf S.","year":"2000","journal-title":"New Eng. J. Med."}],"container-title":["Acta Physiologica Hungarica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.akademiai.com\/doi\/pdf\/10.1556\/aphysiol.98.2011.3.2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,22]],"date-time":"2020-05-22T09:37:17Z","timestamp":1590140237000},"score":1,"resource":{"primary":{"URL":"https:\/\/akjournals.com\/doi\/10.1556\/aphysiol.98.2011.3.2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["10.1556\/APhysiol.98.2011.3.2"],"URL":"https:\/\/doi.org\/10.1556\/aphysiol.98.2011.3.2","relation":{},"ISSN":["0231-424X","1588-2683"],"issn-type":[{"value":"0231-424X","type":"print"},{"value":"1588-2683","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,9]]}}}